Cargando…

Printing of small molecular medicines from the vapor phase

There is growing need to develop efficient methods for early-stage drug discovery, continuous manufacturing of drug delivery vehicles, and ultra-precise dosing of high potency drugs. Here we demonstrate the use of solvent-free organic vapor jet printing to deposit nanostructured films of small molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalev, Olga, Raghavan, Shreya, Mazzara, J. Maxwell, Senabulya, Nancy, Sinko, Patrick D., Fleck, Elyse, Rockwell, Christopher, Simopoulos, Nicholas, Jones, Christina M., Schwendeman, Anna, Mehta, Geeta, Clarke, Roy, Amidon, Gregory E., Shtein, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617892/
https://www.ncbi.nlm.nih.gov/pubmed/28955031
http://dx.doi.org/10.1038/s41467-017-00763-6
_version_ 1783267063437983744
author Shalev, Olga
Raghavan, Shreya
Mazzara, J. Maxwell
Senabulya, Nancy
Sinko, Patrick D.
Fleck, Elyse
Rockwell, Christopher
Simopoulos, Nicholas
Jones, Christina M.
Schwendeman, Anna
Mehta, Geeta
Clarke, Roy
Amidon, Gregory E.
Shtein, Max
author_facet Shalev, Olga
Raghavan, Shreya
Mazzara, J. Maxwell
Senabulya, Nancy
Sinko, Patrick D.
Fleck, Elyse
Rockwell, Christopher
Simopoulos, Nicholas
Jones, Christina M.
Schwendeman, Anna
Mehta, Geeta
Clarke, Roy
Amidon, Gregory E.
Shtein, Max
author_sort Shalev, Olga
collection PubMed
description There is growing need to develop efficient methods for early-stage drug discovery, continuous manufacturing of drug delivery vehicles, and ultra-precise dosing of high potency drugs. Here we demonstrate the use of solvent-free organic vapor jet printing to deposit nanostructured films of small molecular pharmaceutical ingredients, including caffeine, paracetamol, ibuprofen, tamoxifen, BAY 11-7082 and fluorescein, with accuracy on the scale of micrograms per square centimeter, onto glass, Tegaderm, Listerine tabs, and stainless steel microneedles. The printed films exhibit similar crystallographic order and chemistry as the original powders; controlled, order-of-magnitude enhancements of dissolution rate are observed relative to powder-form particles. In vitro treatment of breast and ovarian cancer cell cultures in aqueous media by tamoxifen and BAY 11-7082 films shows similar behavior to drugs pre-dissolved in dimethyl sulfoxide. The demonstrated precise printing of medicines as films, without the use of solvents, can accelerate drug screening and enable continuous manufacturing, while enhancing dosage accuracy.
format Online
Article
Text
id pubmed-5617892
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56178922017-10-02 Printing of small molecular medicines from the vapor phase Shalev, Olga Raghavan, Shreya Mazzara, J. Maxwell Senabulya, Nancy Sinko, Patrick D. Fleck, Elyse Rockwell, Christopher Simopoulos, Nicholas Jones, Christina M. Schwendeman, Anna Mehta, Geeta Clarke, Roy Amidon, Gregory E. Shtein, Max Nat Commun Article There is growing need to develop efficient methods for early-stage drug discovery, continuous manufacturing of drug delivery vehicles, and ultra-precise dosing of high potency drugs. Here we demonstrate the use of solvent-free organic vapor jet printing to deposit nanostructured films of small molecular pharmaceutical ingredients, including caffeine, paracetamol, ibuprofen, tamoxifen, BAY 11-7082 and fluorescein, with accuracy on the scale of micrograms per square centimeter, onto glass, Tegaderm, Listerine tabs, and stainless steel microneedles. The printed films exhibit similar crystallographic order and chemistry as the original powders; controlled, order-of-magnitude enhancements of dissolution rate are observed relative to powder-form particles. In vitro treatment of breast and ovarian cancer cell cultures in aqueous media by tamoxifen and BAY 11-7082 films shows similar behavior to drugs pre-dissolved in dimethyl sulfoxide. The demonstrated precise printing of medicines as films, without the use of solvents, can accelerate drug screening and enable continuous manufacturing, while enhancing dosage accuracy. Nature Publishing Group UK 2017-09-27 /pmc/articles/PMC5617892/ /pubmed/28955031 http://dx.doi.org/10.1038/s41467-017-00763-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Shalev, Olga
Raghavan, Shreya
Mazzara, J. Maxwell
Senabulya, Nancy
Sinko, Patrick D.
Fleck, Elyse
Rockwell, Christopher
Simopoulos, Nicholas
Jones, Christina M.
Schwendeman, Anna
Mehta, Geeta
Clarke, Roy
Amidon, Gregory E.
Shtein, Max
Printing of small molecular medicines from the vapor phase
title Printing of small molecular medicines from the vapor phase
title_full Printing of small molecular medicines from the vapor phase
title_fullStr Printing of small molecular medicines from the vapor phase
title_full_unstemmed Printing of small molecular medicines from the vapor phase
title_short Printing of small molecular medicines from the vapor phase
title_sort printing of small molecular medicines from the vapor phase
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617892/
https://www.ncbi.nlm.nih.gov/pubmed/28955031
http://dx.doi.org/10.1038/s41467-017-00763-6
work_keys_str_mv AT shalevolga printingofsmallmolecularmedicinesfromthevaporphase
AT raghavanshreya printingofsmallmolecularmedicinesfromthevaporphase
AT mazzarajmaxwell printingofsmallmolecularmedicinesfromthevaporphase
AT senabulyanancy printingofsmallmolecularmedicinesfromthevaporphase
AT sinkopatrickd printingofsmallmolecularmedicinesfromthevaporphase
AT fleckelyse printingofsmallmolecularmedicinesfromthevaporphase
AT rockwellchristopher printingofsmallmolecularmedicinesfromthevaporphase
AT simopoulosnicholas printingofsmallmolecularmedicinesfromthevaporphase
AT joneschristinam printingofsmallmolecularmedicinesfromthevaporphase
AT schwendemananna printingofsmallmolecularmedicinesfromthevaporphase
AT mehtageeta printingofsmallmolecularmedicinesfromthevaporphase
AT clarkeroy printingofsmallmolecularmedicinesfromthevaporphase
AT amidongregorye printingofsmallmolecularmedicinesfromthevaporphase
AT shteinmax printingofsmallmolecularmedicinesfromthevaporphase